Humana Inc.

1. 01

   Ahead of SPY and its sector fund XLV over 1 year

   1 month: +3.3% (SPY −1.6%, XLV +13.5%). 3 months: +14.7% (SPY −0.4%, XLV +15.5%). 1 year: +48.1% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: HUM, SPY and XLV · as of 4 Nov 2026

2. 02

   P/E 71.2% above its peers' median

   Trailing P/E of 39.7 against a median of 23.2 across 5 peers named in its company record (range 12.5 to 26.0).

   Quote feed P/E (price ÷ trailing 12-month EPS); peers as named in the company record · as of 4 Nov 2026

3. 03

   8.6% below its 52-week high

   Closed at $417.42 on 4 Nov 2026: 8.6% below the 52-week high of $456.50 (9 Oct 2026) and 155.9% above the low of $163.11 (20 Mar 2026).

   Daily price bars, split-adjusted · as of 4 Nov 2026

4. 04

   Above its 50- and 200-day averages

   The 4 Nov 2026 close of $417.42 was 3.6% above its 50-day average ($402.84) and 34.5% above its 200-day average ($310.44). It has closed above the 200-day for 127 sessions, since 6 May 2026. The 50-day average crossed above the 200-day on 5 Jun 2026, 105 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

5. 05

   Short interest at 3.1% of shares outstanding

   3.7M shares were sold short at the 15 Oct 2026 settlement, 3.1% of the 120.1M shares outstanding; covering them would take 2.0 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

At the 4 Nov 2026 close